BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34224597)

  • 1. Universal two-point interaction of mediator KIX with 9aaTAD activation domains.
    Hofrova A; Lousa P; Kubickova M; Hritz J; Otasevic T; Repko M; Knight A; Piskacek M
    J Cell Biochem; 2021 Oct; 122(10):1544-1555. PubMed ID: 34224597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared structural features of the 9aaTAD family in complex with CBP.
    Piskacek M; Vasku A; Hajek R; Knight A
    Mol Biosyst; 2015 Mar; 11(3):844-51. PubMed ID: 25564305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD.
    Houser J; Jendruchova K; Knight A; Piskacek M
    Biochem J; 2023 May; 480(5):297-306. PubMed ID: 36825663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
    Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
    J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain.
    Arai M; Dyson HJ; Wright PE
    FEBS Lett; 2010 Nov; 584(22):4500-4. PubMed ID: 20969867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.
    Goto NK; Zor T; Martinez-Yamout M; Dyson HJ; Wright PE
    J Biol Chem; 2002 Nov; 277(45):43168-74. PubMed ID: 12205094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for cooperative transcription factor binding to the CBP coactivator.
    De Guzman RN; Goto NK; Dyson HJ; Wright PE
    J Mol Biol; 2006 Feb; 355(5):1005-13. PubMed ID: 16253272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
    Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
    J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.
    Korkmaz EN; Nussinov R; Haliloğlu T
    PLoS Comput Biol; 2012; 8(3):e1002420. PubMed ID: 22438798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting allostery in CREB-binding protein (CBP) using residue-based interaction energy.
    Yazar M; Ozbek P
    J Comput Aided Mol Des; 2020 Sep; 34(9):965-974. PubMed ID: 32430574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepaying the entropic cost for allosteric regulation in KIX.
    Law SM; Gagnon JK; Mapp AK; Brooks CL
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12067-72. PubMed ID: 25002472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.
    Ernst P; Wang J; Huang M; Goodman RH; Korsmeyer SJ
    Mol Cell Biol; 2001 Apr; 21(7):2249-58. PubMed ID: 11259575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
    Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
    Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs.
    Piskacek M; Havelka M; Jendruchova K; Knight A; Keegan LP
    Cell Mol Life Sci; 2020 May; 77(9):1793-1810. PubMed ID: 31375868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of pKID/KIX Association Studied by Molecular Dynamics Free Energy Simulations.
    Bomblies R; Luitz MP; Zacharias M
    J Phys Chem B; 2016 Aug; 120(33):8186-92. PubMed ID: 27054660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of binding of the KIX domain to the mixed lineage leukemia protein and its allosteric role in the recognition of c-Myb.
    Toto A; Giri R; Brunori M; Gianni S
    Protein Sci; 2014 Jul; 23(7):962-9. PubMed ID: 24753318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct observation of the dynamic process underlying allosteric signal transmission.
    Brüschweiler S; Schanda P; Kloiber K; Brutscher B; Kontaxis G; Konrat R; Tollinger M
    J Am Chem Soc; 2009 Mar; 131(8):3063-8. PubMed ID: 19203263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational peptide design for inhibition of the KIX-MLL interaction.
    Sato N; Suetaka S; Hayashi Y; Arai M
    Sci Rep; 2023 Apr; 13(1):6330. PubMed ID: 37072438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
    Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
    Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.